BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33787990)

  • 1. [Randomized controlled multicenter study of albumin replacement therapy in septic shock (ARISS)].
    Sakr Y; Gattinoni L;
    Anaesthesist; 2021 Jun; 70(6):528-530. PubMed ID: 33787990
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial.
    Sakr Y; Bauer M; Nierhaus A; Kluge S; Schumacher U; Putensen C; Fichtner F; Petros S; Scheer C; Jaschinski U; Tanev I; Jacob D; Weiler N; Schulze PC; Fiedler F; Kapfer B; Brunkhorst F; Lautenschlaeger I; Wartenberg K; Utzolino S; Briegel J; Moerer O; Bischoff P; Zarbock A; Quintel M; Gattinoni L;
    Trials; 2020 Dec; 21(1):1002. PubMed ID: 33287911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Concentrations of Albumin Versus Crystalloid in Patients with Sepsis and Septic Shock: A Meta-Analysis of Randomized Clinical Trials.
    Geng L; Tian X; Gao Z; Mao A; Feng L; He C
    J Intensive Care Med; 2023 Aug; 38(8):679-689. PubMed ID: 37078161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial.
    Cortegiani A; Grasselli G; Meessen J; Moscarelli A; Ippolito M; Turvani F; Bonenti CM; Romagnoli S; Volta CA; Bellani G; Giarratano A; Latini R; Pesenti A; Caironi P
    J Crit Care; 2021 Jun; 63():83-91. PubMed ID: 33636427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of albumin and crystalloid on mortality among patients with septic shock: systematic review with meta-analysis and trial sequential analysis.
    Zou Y; Ma K; Xiong JB; Xi CH; Deng XJ
    Sao Paulo Med J; 2018; 136(5):421-432. PubMed ID: 30570093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resuscitation with hyperoncotic colloids in the intensive care unit.
    Wiedermann CJ
    Intensive Care Med; 2009 Feb; 35(2):381; author reply 382-3. PubMed ID: 19107462
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
    Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
    Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicountry survey of emergency and critical care medicine physicians' fluid resuscitation practices for adult patients with early septic shock.
    McIntyre L; Rowe BH; Walsh TS; Gray A; Arabi Y; Perner A; Gordon A; Marshall J; Cook D; Fox-Robichaud A; Bagshaw SM; Green R; Schweitzer I; Turgeon A; Zarychanski R; English S; Chassé M; Stiell I; Fergusson D;
    BMJ Open; 2016 Jul; 6(7):e010041. PubMed ID: 27388345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.
    Xu JY; Chen QH; Xie JF; Pan C; Liu SQ; Huang LW; Yang CS; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
    Crit Care; 2014 Dec; 18(6):702. PubMed ID: 25499187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New recommendations on the use of human albumin solutions in patients with severe sepsis and septic shock. A critical evaluation of the literature].
    Latour-Pérez J
    Med Intensiva; 2013; 37(6):409-15. PubMed ID: 23664006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin replacement in patients with severe sepsis or septic shock.
    Caironi P; Tognoni G; Masson S; Fumagalli R; Pesenti A; Romero M; Fanizza C; Caspani L; Faenza S; Grasselli G; Iapichino G; Antonelli M; Parrini V; Fiore G; Latini R; Gattinoni L;
    N Engl J Med; 2014 Apr; 370(15):1412-21. PubMed ID: 24635772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
    Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L
    Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is albumin a real alternative to starches in septic patients?
    Uña Orejón R; Del Huercio Martinez I; Ureta Tolsada MP
    Rev Esp Anestesiol Reanim; 2017 Oct; 64(8):483-484. PubMed ID: 28341081
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
    Røsjø H; Masson S; Caironi P; Stridsberg M; Magnoli M; Christensen G; Moise G; Urbano MC; Gattinoni L; Pesenti A; Latini R; Omland T;
    Crit Care Med; 2018 May; 46(5):e404-e410. PubMed ID: 29481425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of volume resuscitation in children with septic shock].
    Huo X; Wang X; Kang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Apr; 26(4):253-7. PubMed ID: 24709498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin.
    Piecuch S
    Crit Care Med; 2006 Feb; 34(2):579; author reply 579. PubMed ID: 16424767
    [No Abstract]   [Full Text] [Related]  

  • 18. Albumin administration in septic shock-Protocol for post-hoc analyses of data from a multicentre RCT.
    Meyhoff TS; Granholm A; Hjortrup PB; Sivapalan P; Lange T; Laake JH; Cronhjort M; Jakob SM; Cecconi M; Nalos M; Ostermann M; Malbrain MLNG; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2023 Sep; 67(8):1128-1136. PubMed ID: 37246841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cost-effectiveness Analysis of Albumin in Septic Shock: A Patient-level Data Analysis.
    Tigabu BM; Davari M; Kebriaeezadeh A; Mojtahedzadeh M; Sadeghi K; Najmeddin F; Jahangard-Rafsanjani Z
    Clin Ther; 2019 Nov; 41(11):2297-2307.e2. PubMed ID: 31668842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of resuscitation with human albumin 5%, hydroxyethyl starch 130/0.4 6%, or crystalloid on kidney damage in an ovine model of septic shock.
    Kampmeier TG; Arnemann PH; Hessler M; Bockbreder K; Wald A; Morelli A; Rehberg SW; Ertmer C
    Br J Anaesth; 2018 Sep; 121(3):581-587. PubMed ID: 30115256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.